Pharmacovigilance and Drug Safety Software accelerates the identification of unexpected drug interactions and safety trends across broad patient demographics.
The pharmacovigilance and drug safety software market was valued at US$ 1.97 billion in 2021 and is expected to reach US$ 3.29 billion by 2031. The market is expected to register a CAGR of 5.9% in 2023–2031.
What is driving...